Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Clinical trial NCT00992446 · COMPLETED

Trial details

NCT number: NCT00992446
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Diffuse Large B-Cell Lymphoma B-Cell Non-Hodgkin Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma T-Cell Non-Hodgkin Lymphoma

Start date: 2010-09-02
Primary completion: 2015-06-17
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.